Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults

John G. Bartlett,1 Scott F Dowell,2 Lionel A. Mandell,6 Thomas M. File, Jr.,3 Daniel M. Musher,4 and Michael J. Fine5 'Johns Hopkins University School of Medicine, Baltimore, Maryland, 2Centers for Disease Control and Prevention, Atlanta, Georgia, 3Northeastern Ohio Universities College of Medicine, Cleveland, Ohio, 4Baylor College of Medicine and Veterans Affairs Medical Center, Houston, Texas, and 5University of Pittsburgh, Pennsylvania, USA; and 6McMaster University, Toronto, Canada

• Publication year

  2000

• Venue

  Clinical Infectious Diseases

• Publication date

  2000-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1086/313954PMID 10987697PMCID 7109923
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic accuracy of transtracheal aspiration bacteriologic studies.

  2015cited by this paper
• A fiberoptic bronchoscopy technique to obtain uncontaminated lower airway secretions for bacterial culture.

  2015cited by this paper
• Should fiberoptic bronchoscopy aspirates be cultured?

  2015cited by this paper
• The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia.

  2015cited by this paper
• Community-acquired pneumonia.

  2013cited by this paper
• Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.

  2011cited by this paper
• Rapid diagnostic tests for influenza

  2003cited by this paper
• Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.

  2000cited by this paper
• Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial.

  2000cited by this paper
• Abortion surveillance--United States, 1997.

  2000cited by this paper
• Bacteremic and Nonbacteremic Pneumococcal Pneumonia A Prospective Study

  2000cited by this paper
• A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.

  2000cited by this paper
• DECREASED SUSCEPTIBILITY OF STREPTOCOCCUS PNEUMONIAE TO FLUOROQUINOLONES IN CANADA

  2000cited by this paper
• Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  2000cited by this paper
• Emergence of Fluoroquinolone Resistance among Multiply Resistant Strains of Streptococcus pneumoniae in Hong Kong

  1999cited by this paper
• All-terrain vehicle-related deaths--West Virginia, 1985-1997.

  1999cited by this paper
• Anthrax as a biological weapon: Medical and public health management: Inglesby TV, Henderson DA, Bartlett JG, et al JAMA 281: 1735–1745 May 1999

  1999cited by this paper
• Does this patient have community-acquired pneumonia?

  1999cited by this paper
• Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

  1999cited by this paper
• Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.

  1999cited by this paper
• Decreasing antibiotic use in ambulatory practice: impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults.

  1999influential reference
• Antimicrobial Activities and Postantibiotic Effects of Clarithromycin, 14-Hydroxy-Clarithromycin, and Azithromycin in Epithelial Cell Lining Fluid against Clinical Isolates ofHaemophilus influenzae and Streptococcus pneumoniae

  1999cited by this paper
• The Cost of Treating Patients with Community-Acquired Pneumonia

  1999cited by this paper
• Long-term studies of hantavirus reservoir populations in the southwestern United States: rationale, potential, and methods.

  1999cited by this paper
• Update: hantavirus pulmonary syndrome--United States, 1999.

  1999cited by this paper
• Failure of treatment of pneumonia associated with highly resistant pneumococci in a child.

  1999cited by this paper
• Pneumococcal macrolide resistance--myth or reality?

  1999cited by this paper
• Diagnosing pneumonia by physical examination: relevant or relic?

  1999cited by this paper
• Anthrax as a biological weapon: medical and public health management. Working Group on Civilian Biodefense.

  1999cited by this paper
• Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study.

  1999cited by this paper
• The looming threat of bioterrorism.

  1999cited by this paper
• Effectiveness of influenza vaccine in health care professionals: a randomized trial.

  1999cited by this paper
• Comparison of PCR, Culture, and Serological Tests for Diagnosis of Mycoplasma pneumoniae Respiratory Tract Infection in Children

  1999influential reference
• Antibiotics in acute bronchitis: a meta-analysis

  1999cited by this paper
• Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment.

  1999influential reference
• Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.

  1998cited by this paper
• Medical Management of Biological Casualties Handbook [Third Edition]

  1998cited by this paper
• Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.

  1998cited by this paper
• AIRWAY INFECTION

  1998cited by this paper
• Diagnosis of Mycoplasma pneumoniaePneumonia in Children

  1998cited by this paper
• Increased incidence of ciprofloxacin resistance in penicillin-resistant pneumococci in Northern Ireland.

  1998cited by this paper
• Community-acquired pneumonia

  1998cited by this paper
• An outbreak of hantavirus pulmonary syndrome, Chile, 1997.

  1998cited by this paper
• Safely increasing the proportion of patients with community-acquired pneumonia treated as outpatients: an interventional trial.

  1998cited by this paper
• Antimicrobial Chemotherapy for Legionnaires Disease: Time for a Change

  1998cited by this paper
• Telephone call reminders and attendance in an adolescent clinic.

  1998cited by this paper
• National trends in the use of antibiotics by primary care physicians for adult patients with cough.

  1998cited by this paper
• Management of Infections Due to Antibiotic-Resistant Streptococcus pneumoniae

  1998cited by this paper
• Cough Illness/Bronchitis—Principles of Judicious Use of Antimicrobial Agents

  1998cited by this paper
• Acute bronchitis.

  1998cited by this paper
• Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.

  1998cited by this paper
• Treating influenza with zanamivir.

  1998cited by this paper
• High-resolution computed tomography for the diagnosis of community-acquired pneumonia.

  1998cited by this paper
• Prevalence of antimicrobial resistance among respiratory tract isolates of Streptococcus pneumoniae in North America: 1997 results from the SENTRY antimicrobial surveillance program.

  1998influential reference
• Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections.

  1998cited by this paper
• Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

  1997cited by this paper
• The impact of alcohol-related diagnoses on pneumonia outcomes.

  1997cited by this paper
• The hospital admission decision for patients with community-acquired pneumonia. Results from the pneumonia Patient Outcomes Research Team cohort study.

  1997cited by this paper
• Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory

  1997influential reference
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997influential reference
• Influenza surveillance--United States, 1992-93 and 1993-94.

  1997cited by this paper
• Preventing the emergence of antimicrobial resistance. A call for action by clinicians, public health officials, and patients.

  1997cited by this paper
• Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians.

  1997cited by this paper
• Hantaviruses: a global disease problem.

  1997cited by this paper
• Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

  1997influential reference
• Doxycycline revisited.

  1997cited by this paper
• Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections

  1997cited by this paper
• Injuries and deaths associated with use of snowmobiles--Maine, 1991-1996.

  1997cited by this paper
• Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group.

  1997influential reference
• Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

  1997cited by this paper
• The hospital discharge decision for patients with community-acquired pneumonia. Results from the Pneumonia Patient Outcomes Research Team cohort study.

  1997cited by this paper
• A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia

  1997cited by this paper
• Introduction to Table V. Premature deaths, monthly mortality, and monthly physician contacts--United States.

  1997cited by this paper
• Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia.

  1997cited by this paper
• Susceptibility of penicillin-susceptible and -resistant pneumococci to dirithromycin compared with susceptibilities to erythromycin, azithromycin, clarithromycin, roxithromycin, and clindamycin

  1997cited by this paper
• Influenza Vaccination of Health Care Workers in Long-Term-Care Hospitals Reduces the Mortality of Elderly Patients

  1997cited by this paper
• Incidence of Community-Acquired Pneumonia Requiring Hospitalization Results of a Population-Based Active Surveillance Study in Ohio

  1997cited by this paper
• Quality of care, process, and outcomes in elderly patients with pneumonia.

  1997influential reference
• Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.

  1997cited by this paper
• Legionellosis.

  1997cited by this paper
• Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.

  1997cited by this paper
• Bacteremia with Streptococcus pneumoniae. Implications for therapy and prevention. Franklin County Pneumonia Study Group.

  1996cited by this paper
• Authorities address US drug-related 'arms race'.

  1996cited by this paper
• Comparison of Three Regimens for Treatment of Mild to Moderate Pneumocystis carinii Pneumonia in Patients with AIDS: A Double-Blind, Randomized Trial of Oral Trimethoprim-Sulfamethoxazole, Dapsone-Trimethoprim, and Clindamycin-Primaquine

  1996cited by this paper
• Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis.

  1996influential reference
• Streptococcus pneumoniae resistance to fluoroquinolones

  1996cited by this paper
• Hantavirus pulmonary syndrome: the first 100 US cases.

  1996cited by this paper
• Early recognition of Streptococcus pneumoniae in patients with community-acquired pneumonia.

  1996cited by this paper
• Treatment of acute bronchitis in adults without underlying lung disease

  1996cited by this paper
• Prevention of pneumococcal disease.

  1996cited by this paper
• Infections due to species of Mycoplasma and Ureaplasma: an update.

  1996influential reference
• Appropriateness of hospitalization of patients with community-acquired pneumonia.

  1996cited by this paper
• Prevalence and incidence of adult pertussis in an urban population.

  1996cited by this paper
• Preferences for home vs hospital care among low-risk patients with community-acquired pneumonia.

  1996cited by this paper
• Acid aspiration induced lung injury. New insights and therapeutic options.

  1996cited by this paper
• Community‐Acquired Pneumonia: Impact of Immune Status

  1996cited by this paper
• Comparative activities of LY 333328, a new glycopeptide, against penicillin-susceptible and -resistant pneumococci

  1996cited by this paper
• Diagnostic methods for intracellular pathogens.

  1996cited by this paper
• Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci

  1996cited by this paper
• Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen.

  1996cited by this paper

• A Descriptive Study on Clinical Pulmonary Infection Score (CPIS) in Early Identification of Hospital-Acquired Pneumonia (HAP) Among Critically Ill Patients in a Tertiary Care Teaching Hospital

  2025cites this paper
• Risk factors associated with mortality in critically ill patients with SARS-CoV-2 pneumonia in a tertiary hospital in Ecuador

  2025influential citation
• Predominance of gram-negative multidrug-resistant pathogens causing lower respiratory tract infections among gene X-pert negative presumptive tuberculosis patients in Dar Es Salaam, Tanzania

  2025cites this paper
• Legionnaires’ disease: A review of emerging public health threats

  2025cites this paper
• Aspiration pneumonia guidelines - Société de Pathologie Infectieuse de Langue Française 2025.

  2025cites this paper
• The Power of RDW/Albumin and BUN/Creatinine Ratio in Predicting Mortality in Patients Admitted to the Emergency Department and Hospitalized in Intensive Care Unit with Pneumonia

  2025cites this paper
• The Role Of Drug Indication On Incidence Rate Heterogeneity: A Large-Scale, Systematic Evaluation Across An International Network Of Observational Databases

  2025cites this paper
• Severe community-acquired pneumonia

  2025influential citation
• Community-acquired Pneumonia in Children.

  2025cites this paper
• Prophylactic endotracheal intubation prior to emergency endoscopy for acute esophagogastric variceal hemorrhage: a retrospective single center study

  2025cites this paper
• Recommandations pour la prise en charge des pneumonies d’inhalation – Société de Pathologie Infectieuse de Langue Française 2025

  2025cites this paper
• Risk factors for complicated community-acquired pneumonia in Egyptian children: a hospital-based 6-month study

  2025cites this paper
• Impact of antibiotic stewardship on infection rates in oral surgery procedures: a descriptive study.

  2025cites this paper
• Why think twice before prescribing proton pump inhibitors

  2025cites this paper
• Effects of Xuebijing Injection on Severe Community-Acquired Pneumonia in ICU

  2025cites this paper
• Incidence of and risk factors for side effects associated with antibiotic treatment for pneumonia.

  2025cites this paper
• Entre a escassez e a necessidade: Disponibilidade e uso de antibióticos no Sistema Único de Saúde

  2025cites this paper
• Adapting International Evidence-Based Guidelines to Local Challenges: A Lebanese perspective on the latest American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA) Community-Acquired Pneumonia Antibacterial Therapy Recommendations.

  2025cites this paper
• Mean platelet volume and red blood cell distribution width coefficient of variation as predictors of prognosis in pneumonia in children

  2025cites this paper
• Thionated levofloxacin derivative: Potential repurposing for cancer treatment and synergism with doxorubicin on doxorubicin-resistant lung cancer cells

  2025cites this paper
• Acute bronchitis: updated clinical guidelines. A review

  2025cites this paper
• Bacterial Infections in Intensive Care Units: Epidemiological and Microbiological Aspects

  2024cites this paper
• Patterns and predictors of positive multiplex polymerase chain reaction respiratory panel among patients with acute respiratory infections in a single center in Lebanon

  2024cites this paper
• Biological evaluation of levofloxacin and its thionated derivatives: antioxidant activity, aldehyde dehydrogenase enzyme inhibition, and cytotoxicity on A549 cell line

  2024cites this paper
• Enhancing pneumonia prognosis in the emergency department: a novel machine learning approach using complete blood count and differential leukocyte count combined with CURB-65 score

  2024cites this paper
• Radiological distribution of bronchiectasis could be a clue for an infrequent cause of chronic cough

  2024cites this paper
• Сontemporary approaches to the treatment of acute bronchitis: benefits of herbal medicine

  2024cites this paper
• Real-World Experience of Ceftobiprole for Community- and Hospital-Acquired Pneumonia from a Stewardship Perspective

  2024cites this paper
• Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study.

  2024cites this paper
• Radiographic Imaging of Community-Acquired Pneumonia: A Case-Based Review.

  2024cites this paper
• Multicentre case–control study of pneumococcal infections among children with pneumonia in Peninsular Malaysia (MY-Pneumo): a study protocol

  2024cites this paper
• Etiology and antimicrobial susceptibility patterns of bacteria causing pneumonia among adult patients with signs and symptoms of lower respiratory tract infections during the COVID-19 pandemic in Mwanza, Tanzania: a cross-sectional study

  2024cites this paper
• Mean platelet volume (MPV) and red blood cell distribution width coefficient of variation (RDW_CV) as prognostic markers in community-acquired pneumonia in children: a cross-sectional study

  2024cites this paper
• The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia

  2024cites this paper
• Quick-Med Recommendation System in Medical Emergencies using Machine Learning

  2024cites this paper
• Combining Focal loss with Cross-entropy loss for Pneumonia Classification with a Weighted Sampling Approach

  2024cites this paper
• Factors associated with an increased risk of developing pneumonia during acute ischemic stroke hospitalization

  2024cites this paper
• Antimicrobial Resistance Pattern of Moraxella catarrhalis and Haemophilus influenza in Iran; a Systematic Review

  2024cites this paper
• Outcome evaluation of pharmacist-physician collaborative protocol-based antimicrobial treatment for hospitalized stroke patients with aspiration pneumonia.

  2024cites this paper
• A Comprehensive Machine Learning Based Ensemble Model for Prediction of Possible Diseases and Recommending Medicines

  2023cites this paper
• Guideline-Concordant Antibiotic Therapy for the Hospital Treatment of Community-Acquired Pneumonia and 1-Year All-Cause and Cardiovascular Mortality in Elderly Patients Surviving to Discharge.

  2023cites this paper
• Study of structurally diverse currently used and recently developed antimycobacterial drugs.

  2023cites this paper
• Oral versus parenteral antibiotic therapy in adult patients with community-acquired pneumonia: A systematic review and meta-analysis of randomized controlled trials.

  2023cites this paper
• A nomogram based on the expression level of angiopoietin-like 4 to predict the severity of community-acquired pneumonia

  2023cites this paper
• Risk Factors of Community-Acquired Pneumonia Among Under-Five Children in a Tertiary Level Hospital in Rajshahi

  2023cites this paper
• Community-Acquired Pneumonia in Children.

  2023cites this paper
• Role of mucoactive therapy in the treatment of acute bronchitis

  2023cites this paper
• Design and Develop Drug Recommender Framework System Based on Multilingual Sentiment Analysis Using RNN

  2023cites this paper
• Antibiotic Treatment for Lower Respiratory Tract Infections in Primary Care: A Register-Based Study Examining the Role of Radiographic Imaging

  2023influential citation
• Applications of microbiology to different forensic scenarios - A narrative review.

  2023cites this paper
• Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics

  2023cites this paper
• The incidence of acute renal failure and high mortality rate in elderly patients hospitalized with community acquired pneumonia.

  2023cites this paper
• Bacteriological Profile and Antibiogram of Respiratory Tract Infections in a Tertiary Care Hospital, Bangladesh

  2023cites this paper
• DRUG RECOMMENDATION SYSTEM

  2023cites this paper
• Clinical efficacy of mucoactive therapy with 7% hypertonic saline in patients with acute bronchitis

  2023cites this paper
• Risk factors for hyponatremia in acute exacerbation chronic obstructive pulmonary disease (AECOPD): a multicenter cross-sectional study

  2023cites this paper
• Acute organ injury and long-term sequelae of severe pneumococcal infections

  2023cites this paper
• Bayesian multitask learning for medicine recommendation based on online patient reviews

  2023cites this paper
• Usefulness of a predictive model to hospitalize patients with low-risk community-acquired pneumonia

  2023cites this paper
• Design and Synthesis of Thionated Levofloxacin: Insights into a New Generation of Quinolones with Potential Therapeutic and Analytical Applications

  2022cites this paper
• Short-Term Exposure to Ciprofloxacin Reduces Proteoglycan Loss in Tendon Explants

  2022cites this paper
• TLRs Gene Polymorphisms Associated with Pneumonia before and during COVID-19 Pandemic

  2022cites this paper
• Outcomes of community acquired pneumonia in a tertiary hospital

  2022cites this paper
• Doxycycline to treat community-acquired pneumonia.

  2022cites this paper
• Amoxicillin+clavulanic acid in community acquired pneumonia: Past, present, and future from an Indian perspective

  2022cites this paper
• Risk Factors Related to Residential Environment of Childhood Community Acquired Pneumonia

  2022cites this paper
• Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study

  2022cites this paper
• Pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Greece using urinary antigen detection tests: the EGNATIA study, November 2017 – April 2019

  2022cites this paper
• Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis

  2022cites this paper
• Defining effective durations of antibiotic therapy for community-acquired pneumonia and urinary tract infections in hospitalized children

  2022cites this paper
• β-Lactam Antibiotics

  2022cites this paper
• Risk Factors for Length of Hospital Stay in Acute Exacerbation Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Study

  2022cites this paper
• Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infection during SARS-CoV-2 Infection

  2022cites this paper
• Implementation of evidence-based nursing care for hospital patients with community-acquired pneumonia

  2022cites this paper
• Predominance of Other Pathogenic Bacteria among Presumptive Tuberculosis Cases Attending Tuberculosis Clinics in Mwanza, Tanzania: A Cross-Sectional Laboratory-Based Study

  2022cites this paper
• Radiographic Imaging of Community-Acquired Pneumonia: A Case-Based Review.

  2022cites this paper
• Validity of pneumonia severity index and CURB-65 severity scoring systems in community acquired pneumonia in an Indian setting.

  2022cites this paper
• Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2

  2022cites this paper
• Platelets, Bacterial Adhesins and the Pneumococcus

  2022cites this paper
• Opioid-Associated Out-of-Hospital Cardiac Arrest: Distinctive Clinical Features and Implications for Health Care and Public Responses: A Scientific Statement From the American Heart Association

  2021cites this paper
• Novel antimicrobial activities of self-nanoemulsifying drug delivery system (SNEDDS) ethyl acetate fraction from Garcinia mangostana L. peels against Staphylococcus epidermidis: Design, optimization, and in vitro studies

  2021cites this paper
• Drug Recommendation System based on Sentiment Analysis of Drug Reviews using Machine Learning

  2021cites this paper
• Bactericidal and Bacteriostatic Antibiotics

  2021cites this paper
• Pleural Infection

  2021cites this paper
• Prospective Evaluation of a Rapid Clinical Metagenomics Test for Bacterial Pneumonia

  2021cites this paper
• A prospective study of prevalence of anti-microbial susceptibility of bacterial isolates in lower respiratory tract infections

  2021cites this paper
• Tenets of a holistic approach to drinking water-associated pathogen research, management, and communication.

  2021cites this paper
• Top 10 Pearls for the Recognition, Evaluation, and Management of Maternal Sepsis

  2021cites this paper
• Fluoroquinolones: a review on anti-tubercular activity

  2021cites this paper
• Nuclear Medicine Imaging of Lung Infection

  2021cites this paper
• Legionella Pneumonia in the ICU: A Tertiary Care Center Experience Over 10 Years

  2021cites this paper
• Study of Various Chemically and Structurally Diverse Currently Clinically Used and Recently Developed Antimycobacterial Drugs

  2021cites this paper
• Predictive Value of the Pneumonia Severity Score on Mortality due to Aspiration Pneumonia

  2021cites this paper
• Impact of acute kidney injury on in-hospital outcomes in Chinese patients with community acquired pneumonia

  2021cites this paper
• Microbiota of Bronchoalveolar Lavage Samples from Patients of Lower Respiratory Tract Infection – A Changing Trend

  2021cites this paper
• A study of association of fluoroquinolones in tendon pathology

  2021cites this paper
• Clinical Features of the 60 Years and Older Patients Infected with 2019 Novel Coronavirus: Can We Predict Mortality Earlier?

  2021cites this paper
• Clinical and microbiological profile of adult inpatients with community acquired pneumonia in Ilorin, North Central, Nigeria

  2020cites this paper
• C-reactive protein influences the doctor’s degree of suspicion of pneumonia in primary care: a prospective observational study

  2020cites this paper
• Acute bronchitis: clinical guidelines

  2020cites this paper